BWM
FBIO icon

Bulltick Wealth Management’s Fortress Biotech FBIO Stock Holding History

Bulltick Wealth Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,667
Closed -$20.3K – 115
2023
Q3 		$20.3K Buy
+4,667
New +$32K ﹤0.01% 116
2021
Q2 		– Sell
-1,893
Closed -$100K – 146
2021
Q1 		$100K Sell
1,893
-1,094
-37% -$61.7K 0.03% 116
2020
Q4 		$142K Buy
+2,987
New +$129K 0.04% 101

Other funds holding FBIO

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bulltick Wealth Management's FBIO Position: Q4 2023 in Review

Bulltick Wealth Management sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 4,667 shares — an estimated $20.3K sold.

Bulltick Wealth Management first reported a position in FBIO in Q4 2020 and held it in 3 quarters. The position peaked at $142K in Q4 2020. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.

  • Bulltick Wealth Management reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
  • Bulltick Wealth Management sold 4,667 Fortress Biotech shares in Q4 2023, an estimated $20.3K.
  • Bulltick Wealth Management first reported a position in Fortress Biotech in Q4 2020 and held it in 3 quarters.
  • Bulltick Wealth Management's Fortress Biotech position peaked at $142K in Q4 2020.
  • 42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.

Based on Bulltick Wealth Management's 13F filing for Q4 2023, filed 14 Feb 2024.